Individuals with a history of thyroid cancer, endocrine disorders and kidney disease shouldnt take Semaglutide, as it can increase the risk of these conditions
This is not actually directly connected to any GLP-1 medication, but rather to sudden rapid weight loss, and can see some muscle loss on the buttocks
Back rskov, C, Holst JJ (April 1987) 'Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2)', Scandinavian Journal of Clinical and Laboratory Investigation , 47/2, 165-74.Back rskov, C, Holst, JJ, Seier Poulsen, S, Kirkegaard, P (Nov 1987) 'Pancreatic and intestinal processing of proglucagon in man', Diabetologia, 30, 874-81
Without the authority to conduct pre-market review, the Bekker team notes, FDA relies on voluntary consumer reports to learn about harmful ingredients in dietary supplements